BENDAMUSTINE : A NEW OPTION FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Cerchione, C. [1 ]
Madonna, E. [1 ]
Marano, L. [1 ]
Pugliese, N. [1 ]
Avilia, S. [1 ]
Cerciello, G. [1 ]
Pane, F. [1 ]
Catalano, L. [1 ]
机构：
[1] AOU Federico II, Hematol, Naples, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1538
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [31] BENDAMUSTINE-BASED-TREATMENT FOR HIGHLY TREATED PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Hernandez-Sanchez, A. M.
    Garcia-Sanchez, R.
    Gonzalez-Fernandez, A.
    Rivas Luque, M.
    Fernandez Fernandez, A.
    Rosell Mas, A. I.
    Caparros Miranda, I.
    Campos Garrigues, A.
    Queipo de LLano, M. P.
    Ramirez, G.
    Heiniger, A. I.
    HAEMATOLOGICA, 2014, 99 : 651 - 651
  • [32] New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma
    Abdallah, Nadine
    Kumar, Shaji K.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 511 - 532
  • [33] Relapsed and Refractory Multiple Myeloma New Therapeutic Strategies
    Gentili, Silvia
    Lonial, Sagar
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 861 - +
  • [34] CarfilzomibIn Relapsed, or Relapsed and Refractory, Multiple Myeloma
    Paul L. McCormack
    Drugs, 2012, 72 : 2023 - 2032
  • [35] Carfilzomib In Relapsed, or Relapsed and Refractory, Multiple Myeloma
    McCormack, Paul L.
    DRUGS, 2012, 72 (15) : 2023 - 2032
  • [36] Therapy of relapsed and relapsed refractory multiple myeloma
    Driessen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
  • [37] Management of Relapsed and Relapsed/Refractory Multiple Myeloma
    Laubach, Jacob P.
    Mitsiades, Constantine S.
    Mahindra, Anuj
    Luskin, Marlise R.
    Rosenblatt, Jacalyn
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Avigan, David
    Raje, Noopur
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Richardson, Paul G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1209 - 1216
  • [38] Bendamustine salvage for relapsed - refractory multiple myeloma: a retrospective analysis of outcomes in heavily pretreated patients
    Singh, Aakanksha
    Agrawal, Narendra
    Haldar, Rohan
    Bhurani, Dinesh
    Raychoudhari, Jyoti Shankar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S211 - S211
  • [39] Preliminary Experience of the Spanish Compassionate Use Registry of Bendamustine in Patients with Relapsed and/or Refractory Multiple Myeloma
    Aguado Bueno, Beatriz
    VicuNa Andres, Isabel
    Entrena, Laura
    De Arriba, Felipe
    Krisnik, Isabel
    Navas, BegoNa
    Callejas, Marta
    Teruel, Anabel
    Lopez, Aurelio
    Gonzalez Lopez, Tomas
    Castillo, Inmaculada
    Perez De Oteyza, Jaime
    De Miguel, Dunia
    Rivas Calvo, Sara
    Rodriguez Posada, Raquel
    Alegre, Adrian
    BLOOD, 2012, 120 (21)
  • [40] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA
    Villa, M. R.
    Gagliardi, A.
    Della Cioppa, P.
    Esposito, M.
    Lucania, A.
    Izzo, G. Nitrato
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2016, 101 : S114 - S114
12345